Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first-line therapy in inflammatory bowel disease. Authors' reply

Han Hee Lee^{1

2}, Jung Min Bae³, Bo-In Lee^{1

2}

Affiliations

¹ Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
² Catholic Photomedicine Research Institute, Seoul, Korea.
³ Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Editorial

Han Hee Lee et al. Aliment Pharmacol Ther. 2018 Sep.

. 2018 Sep;48(6):684-685.

doi: 10.1111/apt.14917.

Han Hee Lee^{1

2}, Jung Min Bae³, Bo-In Lee^{1

2}

¹ Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
² Catholic Photomedicine Research Institute, Seoul, Korea.
³ Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

No abstract available

Comment on

Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population-based cohort study.
Bae JM, Lee HH, Lee BI, Lee KM, Eun SH, Cho ML, Kim JS, Park JM, Cho YS, Lee IS, Kim SW, Choi H, Choi MG. Bae JM, et al. Aliment Pharmacol Ther. 2018 Jul;48(2):196-205. doi: 10.1111/apt.14822. Epub 2018 Jun 5. Aliment Pharmacol Ther. 2018. PMID: 29869804
Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first line therapy in inflammatory bowel disease.
Pariente B, Blondeaux A. Pariente B, et al. Aliment Pharmacol Ther. 2018 Sep;48(6):683-684. doi: 10.1111/apt.14903. Aliment Pharmacol Ther. 2018. PMID: 30132941 No abstract available.